Shanghai Kaibao Pharmaceutical Co.,Ltd Stock: price and insider trades · China
上海凯宝
No insider purchase over the last 90 days. The latest, by 任立旺, was filed 22 Jun 2026.
Shanghai Kaibao Pharmaceutical Co.,Ltd: what insiders have been doing
Shanghai Kaibao Pharmaceutical Co.,Ltd, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SSE / SZSE (CSRC). From 7 November 2025 to 7 November 2026, the disclosure feed for Shanghai Kaibao Pharmaceutical Co.,Ltd logged 2 filings by 2 insiders.
Not one open-market sale was filed. On the buying side, 2 insiders reported 2 purchases totalling €66k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The buyers include 2 board members. One trade stands out by size: a purchase of €39k from 王国明, disclosed on 22 June 2026.
Across the 522 companies tracked on its exchange, the median is 2 filings; at 2 filings, this issuer sits right on that mark. Over the whole record (from 2021), the tally stands at 3 purchases and no sales.
In the case of 2 purchases, another manager of the company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. The clock since the last published purchase (22 June 2026) now reads 139 days.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and Vetoquinol SA. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleSince the insiders bought
- +9.8%Entry CN¥4.39 · Close 06 Nov 2026 CN¥4.82
- +9.8%Entry CN¥4.39 · Close 06 Nov 2026 CN¥4.82
- +27.4%Entry CN¥4.86 · Close at T+365 CN¥6.19
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 48,200 shares@ CN¥32.9412100.0% of flowA股XSHESZSE:273000000754529470Canonical exit: 20 Sept 2026 (T+90)
- 71,000 shares@ CN¥32.9722100.0% of flowA股XSHESZSE:273000000754529820Canonical exit: 20 Sept 2026 (T+90)
- 197,900 shares100.0% of flowA股XSHESZSE:173000004591863000Canonical exit: 21 Oct 2021 (T+90)
3 of 3 declarations
About Shanghai Kaibao Pharmaceutical Co.,Ltd
Shanghai Kaibao is a company specializing in the healthcare and pharmaceutical sector. It is listed on the XSHE market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
